INDICATORS ON SITUS JUDI MBL77 YOU SHOULD KNOW

Not all patients with CLL call for therapy. Regardless of all latest advancements, the iwCLL however recommends watchful observation for clients with asymptomatic illness.86 This recommendation relies on a minimum of two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103